Spot Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Spot Trading's GILD Position: Q3 2017 in Review
Spot Trading increased its Gilead Sciences (GILD) stake by 101% in Q3 2017, buying an estimated $15.5M and bringing the position to 401,976 shares worth $32.6M. The position accounts for 0.56% of the portfolio, ranked #9.
Spot Trading first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.
- Spot Trading held 401,976 shares of Gilead Sciences worth $32.6M as of Q3 2017.
- Spot Trading bought 202,237 Gilead Sciences shares in Q3 2017, an estimated $15.5M.
- Gilead Sciences made up 0.56% of Spot Trading's portfolio in Q3 2017, its #9 holding.
- Spot Trading first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
- 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.
Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.